Adicet Bio posts September 2026 investor presentation
Adicet Bio posted a September 2026 investor presentation highlighting prula-cel clinical progress and IND-cleared ADI-212 with near-term clinic timelines.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.